Pfizer Filing Shows 70 Percent Decline in COVID Vaccine Revenue
Vaccine-maker Pfizer Inc., in a filing to the U.S. Securities Exchange Commission, wrote that its COVID-19 vaccine revenue is down 70 percent in 2023. “Declines largely driven by lower contracted deliveries and demand in international markets and lower U.S. government contracted deliveries, due to transition to new variant vaccines in most markets and the transition […]